Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Based in South Korea, ABL Bio is a leading biotechnology company specializing in the development of innovative bispecific antibody therapies. Through state-of-the-art platforms, ABL Bio focuses on creating transformative solutions for oncology and neurodegenerative diseases.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
ABL Bio is scheduled to report its next quarterly earnings on 11/17/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
ABL Bio last reported quarterly earnings on 3/12/2026 (Q4 2025). Earnings per share (EPS) came in at -734.00 KRW.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.